Literature DB >> 10548149

In vivo detection of apoptotic cell death: a necessary measurement for evaluating therapy for myocarditis, ischemia, and heart failure.

F Blankenberg1, J Narula, H W Strauss.   

Abstract

If life is to continue, cells that have completed their useful function(s) must die in a timely manner. Apoptosis, programmed cell death, is a natural, orderly, energy-dependent process that causes cells to die without inducing an inflammatory response. In the heart, apoptosis plays pivotal roles in the development of myocarditis, cardiomyopathies, transplant rejection, the periinfarct zone in myocardial infarction, and reperfusion injury. Apoptosis is triggered either by a decrease in factors required to maintain the cell in good health or by an increase in factors which cause damage to the cell. When these factors tilt in the direction of death and the cell has sufficient time to respond, a common proteolytic cascade involving cysteine aspartic acid-specific proteases (caspases) is activated to initiate apoptosis. Cells that die by apoptosis autodigest their DNA and nuclear proteins, change the phospholipid composition on the outer surface of their cell membrane, and form lipid enclosed vesicles, which contain noxious intracellular contents, organelles, autodigested cytoplasm, and DNA. The compositional cell membrane phospholipid change that occurs with the onset of apoptosis is marked by the sudden expression of phosphatidylserine (PS), a phospholipid that ordinarily appears on the inner leaflet of the membrane, on the external leaflet of the membrane. The constant exposure of PS during apoptosis makes it an attractive target for radiopharmaceutical imaging. An endogenous human protein, annexin V, has a high affinity (kd = 7 nmol/L) for PS bound to the cell membrane. Fluorescence-labeled annexin V is used for histologic and cell-sorting studies to identify apoptotic cells. Annexin has been radiolabeled and binds to cells undergoing apoptosis in vivo. This review outlines some of the key features of apoptosis as contrasted to necrosis (unregulated cell death) and describes how these processes can be imaged with radionuclide techniques.

Entities:  

Mesh:

Year:  1999        PMID: 10548149     DOI: 10.1016/s1071-3581(99)90026-0

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  22 in total

1.  1H-NMR visible neutral lipids in activated T lymphocytes: relationship to phosphatidylcholine cycling.

Authors:  M F Veale; A J Dingley; G F King; N J King
Journal:  Biochim Biophys Acta       Date:  1996-10-18

Review 2.  Myocyte death and growth in the failing heart.

Authors:  P Anversa; A Leri; C A Beltrami; S Guerra; J Kajstura
Journal:  Lab Invest       Date:  1998-07       Impact factor: 5.662

Review 3.  Caspases: enemies within.

Authors:  N A Thornberry; Y Lazebnik
Journal:  Science       Date:  1998-08-28       Impact factor: 47.728

4.  Imaging of apoptosis (programmed cell death) with 99mTc annexin V.

Authors:  F G Blankenberg; P D Katsikis; J F Tait; R E Davis; L Naumovski; K Ohtsuki; S Kopiwoda; M J Abrams; H W Strauss
Journal:  J Nucl Med       Date:  1999-01       Impact factor: 10.057

5.  In vivo detection and imaging of phosphatidylserine expression during programmed cell death.

Authors:  F G Blankenberg; P D Katsikis; J F Tait; R E Davis; L Naumovski; K Ohtsuki; S Kopiwoda; M J Abrams; M Darkes; R C Robbins; H T Maecker; H W Strauss
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

6.  Technetium-99m HYNIC-annexin V: a potential radiopharmaceutical for the in-vivo detection of apoptosis.

Authors:  K Ohtsuki; K Akashi; Y Aoka; F G Blankenberg; S Kopiwoda; J F Tait; H W Strauss
Journal:  Eur J Nucl Med       Date:  1999-10

Review 7.  A matter of life and cell death.

Authors:  G Evan; T Littlewood
Journal:  Science       Date:  1998-08-28       Impact factor: 47.728

8.  Diffusion and perfusion magnetic resonance imaging of the evolution of hypoxic ischemic encephalopathy in the neonatal rabbit.

Authors:  H E D'Arceuil; A J de Crespigny; J Röther; S Seri; M E Moseley; D K Stevenson; W Rhine
Journal:  J Magn Reson Imaging       Date:  1998 Jul-Aug       Impact factor: 4.813

9.  Evaluation of annexin V as a platelet-directed thrombus targeting agent.

Authors:  J F Tait; M D Cerqueira; T A Dewhurst; K Fujikawa; J L Ritchie; J R Stratton
Journal:  Thromb Res       Date:  1994-09-01       Impact factor: 3.944

Review 10.  Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics.

Authors:  J F Kerr; A H Wyllie; A R Currie
Journal:  Br J Cancer       Date:  1972-08       Impact factor: 7.640

View more
  11 in total

Review 1.  Pathophysiology of valvular heart disease: implications for nuclear imaging.

Authors:  Blasé Carabello
Journal:  J Nucl Cardiol       Date:  2002 Jan-Feb       Impact factor: 5.952

Review 2.  Defining the success of cardiac gene therapy: how can nuclear imaging contribute?

Authors:  Norbert Avril; Frank M Bengel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-01-23       Impact factor: 9.236

3.  Noninvasive detection of cell death: from tracking epitaphs to counting coffins.

Authors:  Jagat Narula; Barry L Zaret
Journal:  J Nucl Cardiol       Date:  2002 Sep-Oct       Impact factor: 5.952

Review 4.  Apoptosis-detecting radioligands: current state of the art and future perspectives.

Authors:  Christophe M M Lahorte; Jean-Luc Vanderheyden; Neil Steinmetz; Christophe Van de Wiele; Rudi A Dierckx; Guido Slegers
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-05-12       Impact factor: 9.236

5.  Second Annual Mario S. Verani, MD, Memorial Lecture: Nuclear cardiology, the next 10 years.

Authors:  Barry L Zaret
Journal:  J Nucl Cardiol       Date:  2004 Jul-Aug       Impact factor: 5.952

6.  Burden of myocardial damage in cardiac allograft rejection: scintigraphic evidence of myocardial injury and histologic evidence of myocyte necrosis and apoptosis.

Authors:  M Puig; M Ballester; X Matías-Guiu; R Bordes; I Carrió; F D Kolodgie; C Pons; A García; M R Aymat; J Marrugat; V Brossa; M Campreciós; J M Padró; J M Caralps; R Virmani; J Prat; J Narula
Journal:  J Nucl Cardiol       Date:  2000 Mar-Apr       Impact factor: 5.952

7.  Calcium-phosphate microprecipitates mimic microparticles when examined with flow cytometry.

Authors:  Michael C Larson; Maia R Luthi; Neil Hogg; Cheryl A Hillery
Journal:  Cytometry A       Date:  2012-11-02       Impact factor: 4.355

Review 8.  Non-invasive in vivo imaging of myocardial apoptosis and necrosis.

Authors:  Albert Flotats; Ignasi Carrió
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-03-14       Impact factor: 9.236

9.  Rnd3 haploinsufficient mice are predisposed to hemodynamic stress and develop apoptotic cardiomyopathy with heart failure.

Authors:  X Yue; X Yang; X Lin; T Yang; X Yi; Y Dai; J Guo; T Li; J Shi; L Wei; G-C Fan; C Chen; J Chang
Journal:  Cell Death Dis       Date:  2014-06-05       Impact factor: 8.469

Review 10.  Small-animal SPECT and SPECT/CT: application in cardiovascular research.

Authors:  Reza Golestani; Chao Wu; René A Tio; Clark J Zeebregts; Artiom D Petrov; Freek J Beekman; Rudi A J O Dierckx; Hendrikus H Boersma; Riemer H J A Slart
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-01-13       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.